The past decade has witnessed tremendous progress in understanding the structure and activation of the NLRP3 inflammasome, as well as its roles in the initiation and progression of various auto-immune and auto-inflammatory diseases, including metabolic disorders, multiple sclerosis, inflammatory bowel syndrome, and CAPS. This evidence concerns the gene NLRP3 and metabolic disease.